SynopsisShort-acting B2 agonists (SABAs) are albuterol, levalbuterol, metaproterenol, and terbutaline, and they are prescribed for bronchospasm caused by COPD, bronchial asthma, or emphysema. Global Short-acting B2 Agonists market is projected to reach US$ 5919 .....
SynopsisA rescue inhaler is a type of inhaler that dispenses medication to relieve or stop the symptoms of an asthma attack. Global Rescue Inhaler market is projected to reach US$ 5919 million in 2029, increasing from US$ 4791 million in 2022, with the CAGR of .....
SynopsisInhalers contain either short-acting or long-acting medicines. Short-acting medicines relax and open the breathing tubes in the lungs. These are called rescue inhalers because they work quickly and help “rescue” a person if breathing suddenly becomes difficult.....
SynopsisThese long-term control medications can help reduce asthma-related swelling and tightening in the airways and some medications also block the immune system chemicals that can trigger asthma symptoms. Global Maintenance Inhaler market is projected to rea.....
SynopsisLong-Acting Beta Agonists (LABAs) are inhaled medications that are used in the treatment of asthma and chronic obstuctive pulmonary disease (COPD). Global Long-acting Beta Agonists market is projected to reach US$ 5479.6 million in 2029, increasing from .....
SynopsisSalmeterol and formoterol are both long-acting beta(2)-adrenoceptor agonists (beta(2)-agonists). Global Long Acting Beta 2 Agonist market is projected to reach US$ 2754.8 million in 2029, increasing from US$ 2154 million in 2022, with the CAGR of 3.5% du.....
SynopsisInhalers are devices that contain medicines used to treat asthma and several other diseases that affect the lungs. Global Rescue and Maintenance Inhalers market is projected to reach US$ 17280 million in 2029, increasing from US$ 13470 million in 2022, w.....
SynopsisInhalers are devices that contain medicines used to treat asthma and several other diseases that affect the lungs. Global Respiratory Inhaler Drug market is projected to reach US$ 17280 million in 2029, increasing from US$ 13470 million in 2022, with the.....
SynopsisKyphoscoliosis is a medical condition characterized by abnormal curvature of the spine in both the sagittal and coronal planes. The condition can range from mild to severe and can be caused by various factors, including congenital abnormalities, neuromuscular .....
SynopsisKyphoscoliosis is a medical condition characterized by abnormal curvature of the spine in both the sagittal and coronal planes. The condition can range from mild to severe and can be caused by various factors, including congenital abnormalities, neuromuscular .....
